title: [A case of recurrent early gastric cancer with peritonitis carcinomatosa successfully treated with TS-1].
abstract: A 62-year-old man with carcinomatous ascites more than 5 years after early gastric cancer operation was admitted to our hospital because of suspected pancreatic cancer, and was diagnosed with a relapse of the gastric cancer. TS-1 was administered at a dose of 120 mg/day. At the end of 1 course a partial response of a decrease of tumor markers and ascites and improvement of QOL was achieved, and the patient was followed in the outpatient clinic. The current case suggests that TS-1 may have a potent therapeutic efficacy in cases of gastric cancer relapse with carcinomatous ascites.
authors.affiliation: Dept. of Gastroenterology, National Kyushu Cancer Center.
authors.forename: Fumika
authors.initials: F
authors.lastname: Hatanaka
authors.forename: Susumu
authors.initials: S
authors.lastname: Matsuo
authors.forename: Yoshifusa
authors.initials: Y
authors.lastname: Aratake
authors.forename: Koutaro
authors.initials: K
authors.lastname: Uchimura
authors.forename: Masaki
authors.initials: M
authors.lastname: Yokota
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Sumii
authors.forename: Haruo
authors.initials: H
authors.lastname: Iguchi
authors.forename: Akihiro
authors.initials: A
authors.lastname: Funakoshi
mesh_terms: D000230:Adenocarcinoma / Q000150:complications / Q000188:drug therapy*; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001201:Ascites / Q000188:drug therapy / Q000209:etiology; D004334:Drug Administration Schedule; D004338:Drug Combinations; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D010094:Oxonic Acid / Q000627:therapeutic use*; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology; D011725:Pyridines / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000150:complications / Q000188:drug therapy*; D005641:Tegafur / Q000627:therapeutic use*
chemical_list: D000964:Antimetabolites, Antineoplastic; D004338:Drug Combinations; D011725:Pyridines; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid